Amalgamated Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,452
| Closed | -$983K | – | 3196 |
|
|
2025
Q1 | $983K | Buy |
7,452
+564
| +8% | +$70.3K | 0.01% | 1027 |
|
|
2024
Q4 | $575K | Hold |
6,888
| – | – | ﹤0.01% | 1252 |
|
|
2024
Q3 | $504K | Sell |
6,888
-34
| -0.5% | -$2.56K | ﹤0.01% | 1297 |
|
|
2024
Q2 | $474K | Buy |
6,922
+3,736
| +117% | +$259K | ﹤0.01% | 1313 |
|
|
2024
Q1 | $220K | Sell |
3,186
-10,208
| -76% | -$702K | ﹤0.01% | 1581 |
|
|
2023
Q4 | $959K | Sell |
13,394
-933
| -7% | -$53.7K | 0.01% | 1184 |
|
|
2023
Q3 | $746K | Buy |
14,327
+152
| +1% | +$8.86K | 0.01% | 1231 |
|
|
2023
Q2 | $898K | Buy |
14,175
+1,187
| +9% | +$74K | 0.01% | 1164 |
|
|
2023
Q1 | $703K | Sell |
12,988
-2,048
| -14% | -$99K | 0.01% | 1266 |
|
|
2022
Q4 | $796K | Buy |
15,036
+213
| +1% | +$10.7K | 0.01% | 1245 |
|
|
2022
Q3 | $690K | Buy |
14,823
+161
| +1% | +$8.41K | 0.01% | 1266 |
|
|
2022
Q2 | $837K | Buy |
14,662
+1,490
| +11% | +$84.5K | 0.01% | 1213 |
|
|
2022
Q1 | $806K | Buy |
13,172
+734
| +6% | +$38.1K | 0.01% | 1317 |
|
|
2021
Q4 | $651K | Sell |
12,438
-135
| -1% | -$5.67K | ﹤0.01% | 1447 |
|
|
2021
Q3 | $469K | Sell |
12,573
-773
| -6% | -$26.9K | ﹤0.01% | 1611 |
|
|
2021
Q2 | $545K | Buy |
13,346
+6,441
| +93% | +$238K | ﹤0.01% | 1599 |
|
|
2021
Q1 | $234K | Sell |
6,905
-591
| -8% | -$20.5K | 0.01% | 1405 |
|
|
2020
Q4 | $238K | Buy |
+7,496
| New | +$197K | 0.01% | 1357 |
|
|
2020
Q1 | – | Sell |
-8,009
| Closed | -$275K | – | 1795 |
|
|
2019
Q4 | $275K | Buy |
+8,009
| New | +$96.1K | 0.01% | 1461 |
|
Other funds holding ITCI
KIM
HNB